Bordi Licia, Vulcano Antonella, Sberna Giuseppe, Nonis Marino, Giacomini Paolo, Maggi Fabrizio, Fontana Carla, Lalle Eleonora
Laboratory of Virology and Biosafety Laboratories, National Institute of Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Laboratory of Microbiology and Biological Bank, National Institute of Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
Microorganisms. 2023 Sep 5;11(9):2239. doi: 10.3390/microorganisms11092239.
Lower respiratory tract infections (LRTIs) occur when there is a lower airway tract infection. They are well-known for increasing the susceptibility of patients to bacterial/fungal co-infections and super-infections. In this study, we present the results of our investigation, which involved 381 consecutive patients admitted to our hospital during the Influenza season from October 2022 to April 2023. Among the 381 specimens, 75 were bronchoalveolar (BAL), and 306 were nasopharyngeal swabs (NPSs). Notably, 34.4% of the examined samples tested positive for SARS-CoV-2. Of these, we observed that 7.96% of NPSs showed positivity only for other respiratory viruses, while a substantial percentage (77%) of BAL specimens exhibited positive results only for bacterial co-infections. The results of our study not only confirm the importance of co-infections in COVID-19 but also emphasize the significance of utilizing rapid diagnostic tests (RDTs) for the timely diagnosis of LRTIs. In fact, RDTs allow for the identification of multiple pathogens, providing clinicians with useful and timely information to establish effective therapy.
下呼吸道感染(LRTIs)是指下气道发生感染时出现的情况。它们因增加患者发生细菌/真菌合并感染和二重感染的易感性而闻名。在本研究中,我们展示了我们的调查结果,该调查涉及2022年10月至2023年4月流感季节期间连续入住我院的381例患者。在381份样本中,75份是支气管肺泡灌洗(BAL)样本,306份是鼻咽拭子(NPSs)。值得注意的是,34.4%的检测样本SARS-CoV-2呈阳性。其中,我们观察到7.96%的NPSs仅对其他呼吸道病毒呈阳性,而相当比例(77%)的BAL样本仅对细菌合并感染呈阳性结果。我们的研究结果不仅证实了合并感染在COVID-19中的重要性,还强调了利用快速诊断测试(RDTs)及时诊断LRTIs的重要性。事实上,RDTs能够识别多种病原体,为临床医生提供有用且及时的信息以制定有效的治疗方案。
Int J Environ Res Public Health. 2022-8-21
Am J Infect Control. 2022-9
J Clin Virol. 2020-5-26
Diagnostics (Basel). 2023-6-9
Cell Res. 2023-7
Front Public Health. 2022
Int J Environ Res Public Health. 2022-2-19